MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2019 International Congress

    Pursuit of Psychosocial Intervention for Depression and Anxiety in Japanese Parkinson’s Disease patients: Two Studies of Cognitive Behavioral Therapy

    I. Shinmei, N. Nishikawa (Tokyo, Japan)

    Objective: From 2013 to the present, we have explored the feasibility of cognitive behavioral therapy (CBT) for Japanese Parkinson’s disease (PD) patients with depression and…
  • 2019 International Congress

    Study of prevalence of Axis-1 DSM-4 psychiatric disorders in patients with parkinsonism in a rural movement disorder clinic in Western India

    D. Desai, S. Singh, S. Desai (Anand, India)

    Objective: To assess the prevalence of Axis-1 DSM-4 [The Diagnostic and Statistical Manual of Mental disorders] psychiatric disorders in patients with Parkinson’s disease [PD], atypical…
  • 2019 International Congress

    The study on brain function network of Parkinson’s disease with depression

    Y. Qiu, L. Wang (Guangzhou, China)

    Objective: To investigate the topological properties and abnormal connections of the networks in Parkinson’s disease (PD) patients with depression (DPD) Background: Depression is one of…
  • 2019 International Congress

    Exploratory analysis of the relationship between pain and mood disturbances in Parkinson’s disease

    C. Vila, A. Sparks, P. Imbriani, N. Caputi, L. Covington, T. Schirinzi, S. Natoli, A. Pisani, P. Ghosh (Washington, DC, USA)

    Objective: This study aims to investigate the relationship between pain and mood disturbances in patients with Parkinson disease (PD). Background: Pain and mood disturbances are…
  • 2019 International Congress

    Depression in Parkinson’s diseaese: Experience of the neurology department in Mohammed VI third level university hospital

    H. El Yachkouri, M. Chraa, N. Kissani (Marrakesh, Morocco)

    Objective: The objectives of this study are to evaluate the frequency of depression in our Parkinson's disease patients, to describe the relationship of depression to…
  • 2019 International Congress

    Prefrontal cortex high beta power correlates with the severity of anxiety and depression in Parkinson’s disease patients

    C. de Hemptinne, W. Chen, C. Racine, A. Seritan, J. Mergenthaler, S. Rajagopalan, J. Ostrem, P. Starr (San Francisco, CA, USA)

    Objective: To investigate the neural correlates of anxiety and depression in PD patients and to develop a novel neurostimulation therapy for these non-motor symptoms. Background:…
  • 2019 International Congress

    Social cognition in Parkinson’s disease

    L. Alonso-Recio, C. Merino, P. Martín, JM. Serrrano (Collado Villalba (madrid), Spain)

    Objective: The aim of the present study was to assess social cognition skills in non-demented Parkinson’s disease (PD) patients. Background: Social cognition is a multidimensional…
  • 2019 International Congress

    Treating Depression in Parkinson’s Disease: a Systematic Literature Review

    C. Farrell, T. Yousaf, M. Politis (London, United Kingdom)

    Objective: To elucidate the most acceptable and effective treatments for the management of depression in Parkinson’s disease (PD) using a systematic review approach. Background: Depression…
  • 2019 International Congress

    Serotonergic function in De Novo Parkinson’s Disease

    HK. Park, JJ. Lee, YM. Park (Goyang, Republic of Korea)

    Objective: We aimed to investigate the central serotonergic function in de novo PD and change in serotonergic function with dopaminergic medications. Background: While dopaminergic dysfunction…
  • 2019 International Congress

    Non motor symptoms Parkinson’s disease

    N. Bagdanova, Z. Zuleiha (Kazan, Russian Federation)

    Objective: 1.To identify the representation and prevalence of non-motor symptoms of PD in the premotor and early motor stages Background: During the period 2016-2018 104 people were…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley